Context Therapeutics Inc. (CNTX) Monday said it has submitted Investigational New Drug (IND) application to the U.S. Food and Drug Administration to start a first-in-human clinical study of its drug candidate CTIM-76.
The company plans to initiate a Phase 1 study to evaluate CTIM-76 in patients with gynecologic and testicular cancers.
For comments and feedback contact: editorial@rttnews.com
Business News
May 08, 2026 15:50 ET Manufacturing and services sector survey results and labor market data from main economies were the highlight on the economics news front this week. Factory orders and jobs report dominated the news flow in the U.S. Similarly, industrial production data from German garnered attention in Europe. In Asia, purchasing managers’ survey results from China and the central bank decision from Australia were in focus.